These data indicate that TRPC6 expression is increased in the medial layer, but not in atheromas of MetS coronary artery wall; and that TRPC6 upregulation in the MetS medial layer is diminished by spironolactone treatment (Suppl. The gene discussed is TRPC6; the disease is metabolic syndrome.